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Miranda et al. (2007) in the August issue
and Jusko et al. (2008) in the present issue
of Environmental Health Perspectives pro-
vide additional evidence of adverse health
effects in children at blood lead levels
(BLLs) < 10 µg/dL—the Centers for
Disease Control and Prevention’s (CDC)
BLL of concern. A surprising feature of the
new data in children with BLLs < 10
µg/dL is the steepness of the blood
lead–IQ curve at these low levels. Nonlinear modeling conducted by
Canfield et al. (2003) suggested a 7.4-point IQ effect (roughly one-
half standard deviation) as lifetime average BLL went from 1 to 10
µg/dL—more than twice as strong a relationship as shown by most
estimates at higher exposures (Treatment of Lead-exposed Children
Trial Group 1998). It may reasonably be asked whether such a strong
relationship is plausible, particularly as there are no directly relevant
animal or in vitro studies that demonstrate a steeper slope for adverse
effects of lead exposure at lower BLLs than observed at higher levels.
The CDC’s National Health and Nutrition Examination
Survey (NHANES) data indicate that the entire population of U.S.
children 1–5 years of age enjoyed a decline in geometric mean BLLs
from about 15 µg/dL in the late 1970s to < 2 µg/dL in 2002 (CDC
2005a), but there is no agreement that IQs have increased by 7
points. Reading scores for 9-year-old children in the United States,
tracked by the National Center for Education Statistics, show little
change from 1980 to 1999, a period that would have corresponded
to the years of greatest blood lead decline in the toddler years of the
tested children (Perie and Moran 2005). Thus, the interpretation of
the recent results may not be obvious. New studies using designs
that exclude or control potential confounding by pica, which can
indicate an underlying developmental delay, or by environmental
hygiene, indicating more widespread lead contamination, would be
especially helpful in assessing these low-level effects.
In the past, the CDC has responded to reports of adverse health
effects at BLLs below the level previously thought to cause harm, by
lowering the BLL that defines a child as lead poisoned. However, in
2005, the CDC and its Advisory Committee on Childhood Lead
Poisoning Prevention, after a review of the available evidence, deter-
mined that children with BLLs < 10 µg/dL should not be consid-
ered lead poisoned as the term is used in the clinical setting (CDC
2005b). In addition, the CDC found that a) no effective, feasible
interventions to reduce BLLs in this range have been demonstrated;
b) no threshold for adverse effects has been identified; and c) given
current laboratory methods, risk for misclassification of children is
high. Thus, the approach of arbitrarily defining a new, lower BLL of
concern was rejected. This decision also is consistent with the recently
released recommendations of the U.S. Preventive Services Task Force
(2006) “against routine screening for elevated blood lead levels in
asymptomatic children aged 1 to 5 years who are at average risk.” 
Rather, the CDC recommends a multitiered approach that
includes case management of children with BLLs > 10 µg/dL
coupled with an increased focus on primary
prevention through the control and elimi-
nation of lead in children’s environments.
The elements of this strategy include:
• State-based strategic plans to eliminate
childhood lead poisoning through a sys-
tematic society-wide effort that includes
legislative and enforcement efforts to
control lead paint hazards, particularly in
the highest-risk housing (CDC 2007)
• A partnership between the CDC, the Environmental Protection
Agency, and the U.S. Department of Housing and Urban
Development to enforce the Residential Lead-Based Paint Hazard
Reduction Act (1992) particularly in housing where children have
repeatedly been identified as having elevated BLLs 
• Elimination of lead in consumer products that are marketed to
children 
• Recommendations that regulatory agencies abandon the practice of
using a BLL of 10 µg/dL as the threshold for enforcement activities. 
These strategies focus on primary prevention of lead exposure to
children, an approach that is in agreement with the conclusions of
Jusko and colleagues (2008) as expressed in their earlier report from
the same cohort (Canfield et al. 2003).
In 1990, the nation adopted an ambitious goal to eliminate
BLLs > 10 µg/dL as a public health problem by 2010. Recent data
indicate that this goal is in sight. However, studies such as those by
Miranda et al. (2007) and Jusko et al. (2008) sound a cautionary
note. For the foreseeable future, lead will continue to contaminate
the environment. Therefore, even after the 2010 goal is achieved,
primary prevention efforts must be maintained to ensure that lead
sources in children’s environments are controlled or eliminated
before children are exposed and that surveillance systems are in
place to ensure that these efforts are effective.
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housing factors that predict risk for nonfatal pediatric injuries, an analysis of
the costs and benefits of removing lead paint from housing before children are
lead poisoned, and a study of the effect of housing policies on the blood lead
levels of poisoned children. 
George G. Rhoads is associate dean and professor of Epidemiology at the
University of Medicine and Dentistry of New Jersey (UMDNJ) School of
Public Health. He served as chair of the Steering Committee for the NIEHS-
sponsored Treatment of Lead-Exposed Children’s Study, a large randomized
study of chelation therapy, has conducted several other randomized trials
bearing on issues in management of lead-exposed children, and currently
serves as chair of the CDC Advisory Committee on Childhood Lead
Poisoning Prevention.
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Therefore, even after the 2010 goal is achieved, primary prevention efforts
must be maintained to ensure that lead sources in children’s environments
are controlled or eliminated before children are exposed and that 
surveillance systems are in place to ensure that these efforts are effective.